Allocation | Control (n=31) | Treatment (n=34) |
Mean±SE age (years) | 7.79±0.68 | 6.69±0.67 |
Female sex | 16 (52%) | 14 (41.2%) |
CF genotype | ||
dF508/dF508 | 19 | 22 |
dF508/other | 11 | 10 |
Other/other | 1 | 2 |
Sputum producer | 38.7% | 14.7% |
Staphylococcus aureus colonisation | 15 (48%) | 13 (38%) |
Antistaphylococcal prophylaxis | 21 (68%) | 18 (53%) |
Ever P aeruginosa in culture >2 years before study entry | 6 (19.4%) | 7 (20.6%) |
Mean±SE FEV1% | 94±3.0 | 107±3.7 |
Mean±SE BMI z-score | −0.16±0.17 | 0.25±0.14 |
BMI, body mass index; FEV1, forced expiratory volume in 1 s.